Medicaid · every state

Which states' Medicaid covers Wegovy and Zepbound for weight loss?

Last updated

Without Medicaid: the lowest compounded prices now

  • Lowest compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Lowest compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

10 state Medicaid programs cover GLP-1s for weight loss, usually with prior authorization: Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and Wisconsin. KFF counted 13 as of January 2026 (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026); since then Utah, Massachusetts, and Rhode Island have ended theirs, by their own notices, quoted on each state's page. In every other state Medicaid covers GLP-1s for type 2 diabetes and for the other uses it must cover, not for weight loss alone.

10 programs

Medicaid covers GLP-1s for weight loss

7 programs

Medicaid ended its coverage for weight loss

34 programs

Medicaid does not cover GLP-1s for weight loss alone

Questions

Medicaid and GLP-1s: common questions

Which states' Medicaid covers Wegovy or Zepbound for weight loss?

10 state Medicaid programs cover GLP-1s for weight loss, usually with prior authorization: Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and Wisconsin. KFF counted 13 as of January 2026 (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026); since then Utah, Massachusetts, and Rhode Island have ended theirs, by their own notices, quoted on each state's page. In every other state Medicaid covers GLP-1s for type 2 diabetes and for the other uses it must cover, not for weight loss alone.

Which states stopped Medicaid coverage of GLP-1s for weight loss?

California, Massachusetts, New Hampshire, Pennsylvania, Rhode Island, South Carolina, and Utah. KFF named California, New Hampshire, Pennsylvania and South Carolina in January 2026; Utah on Jun 30, 2026, Massachusetts on Jul 3, 2026, Rhode Island on Oct 1, 2026, each by its own notice.

Does Medicaid have to cover GLP-1s?

Only for some uses. In KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively" (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026).

Will Indiana Medicaid cover GLP-1s for weight loss?

It has said it will join CMS's BALANCE model: "Indiana Governor Mike Braun today directed the Indiana Family and Social Services Administration (FSSA) to participate in the Center for Medicare and Medicaid Innovation’s BALANCE demonstration, expanding access to select GLP-1 medications for eligible Indiana Medicaid members living with obesity." (Indiana Governor's release, July 30, 2026, events.in.gov, read Nov 17, 2026). The release names no start date. Indiana Medicaid and GLP-1s

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a Medicaid plan covers is decided by the plan and the state, and changes; ask your plan before you rely on it. This page reports the states' and KFF's published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.